Page last updated: 2024-10-28

hexamethylene bisacetamide and Leukemia, Basophilic, Acute

hexamethylene bisacetamide has been researched along with Leukemia, Basophilic, Acute in 1 studies

N,N'-diacetyl-1,6-diaminohexane: chemical name obtained from Acta Biol Hung 1990;41(1-3):199-208

Leukemia, Basophilic, Acute: A rare acute myeloid leukemia in which the primary differentiation is to BASOPHILS. It is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. Mature basophils are usually sparse.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaves-Dias, C1
Hundley, TR1
Gilfillan, AM1
Kirshenbaum, AS1
Cunha-Melo, JR1
Metcalfe, DD1
Beaven, MA1

Other Studies

1 other study available for hexamethylene bisacetamide and Leukemia, Basophilic, Acute

ArticleYear
Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells: comparisons with tumor mast-cell lines.
    Journal of immunology (Baltimore, Md. : 1950), 2001, Jun-01, Volume: 166, Issue:11

    Topics: Acetamides; Androstadienes; Animals; Antigens, CD34; CD13 Antigens; Cell Cycle; Cell Differentiation

2001